- Revenue is flat
- They are clearly doing some minor cost-out of Sales/Marking and R&D (which is why the loss is 2M less than last year), the opposite to a growth company
- And recievables is up to 1.2M
- <5M cash at the end of Mar they will have almost burnt through in the next month or so....
Old me would have kept my parcel of PEB in the hope they'll come right one day but new me was selling everything at a steep loss at $1.28 way back in 2013. I hope anyone who got stung by PEB will learn from this as did I from other examples.
They make up for it by mentioning CMS eight or nine times.... ;-)
This from the NZX ann, "Management is focused on completing agreements and building sales from the large institutional accounts and payers it is targeting, including Kaiser Permanente." So KP agreement is now not complete?
Bookmarks